SCHEDULE 13G: Lagoda Investment Management Discloses 5.1% Passive Stake in Stereotaxis, Inc.

Lagoda Investment Management, L.P. has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in medical technology company Stereotaxis, Inc. as of March 31, 2025.

Summary

• Lagoda Investment Management, L.P. (the "Reporting Person") filed a Schedule 13G with the SEC.
• The filing indicates that Lagoda Investment Management, L.P. beneficially owns 4,380,450 shares of Stereotaxis, Inc. Common Stock.
• This ownership represents 5.1% of Stereotaxis, Inc.'s total outstanding Common Stock.
• The shares are held in managed accounts for which Lagoda Investment Management, L.P. serves as the investment manager.
• The Reporting Person holds sole voting power and sole dispositive power over all 4,380,450 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Stereotaxis, Inc.

Sentiment

Score: 5

Explanation: Neutral. A Schedule 13G filing is a routine disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It simply reports a significant stake.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Stereotaxis, Inc.'s future outlook.

Industry Context

This document is a beneficial ownership filing by an investment firm and does not provide specific analysis of broader industry trends or competitors for Stereotaxis, Inc.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant passive institutional investor's stake in the company, which may be viewed as a signal of confidence or interest.

Key Dates

Keywords

Stereotaxis, Inc., Lagoda Investment Management, L.P., Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser